35052
6167
4976
189
10
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T2127 | OF-1 | Epigenetic Reader Domain | |
OF-1 is a potent inhibitor of BRPF1B and BRPF2 bromodomain. | |||
T7676 | LSKL, Inhibitor of Thrombospondin TSP-1 acetate | LSKL, Inhibitor of Thrombospondin TSP-1 | TGF-beta/Smad |
LSKL, Inhibitor of Thrombospondin TSP-1 acetate is activation of TGF-β . | |||
T9794 | Cpd.5 of 2234271-86-2 | ||
cpd.5 of 2234271-86-2 is a useful organic compound for research related to life sciences. The catalog number is T9794 and the CAS number is 2234284-82-1. | |||
T12041 | MIM1 | Inhibitor of Mcl-1 | BCL |
MIM1 (Inhibitor of Mcl-1) is an myeloid cell factor 1 (Mcl-1) inhibitor. | |||
T4245 | IWP-4 | Inhibitor of Wnt Production-4 | Wnt/beta-catenin |
IWP-4 (Inhibitor of Wnt Production-4) is a potent Wnt inhibitor. | |||
T36592 | Impurity of Calcipotriol | ||
Impurity of Calcipotriol is an impurity in calcipotriol, a synthetic VitD3 analog. | |||
T19370 | Impurity of Doxercalciferol | Others | |
Impurity of Doxercalciferol is an impurity of doxercalciferol, which is a synthetic analog of ergocalciferol. Impurity of Doxercalciferol used as a drug for secondary hyperparathyroidism and metabolic bone disease, and i... | |||
T11195 | Enantiomer of Sofosbuvir | Others | |
Sofosbuvir's enantiomer, a variant of the prescription medication Sofosbuvir used for chronic hepatitis C treatment, currently lacks reported biological activity. | |||
T11645 | Impurity C of Calcitriol | Others | |
Impurity C of Calcitriol is an impurity of Calcitriol.Impurity C of Calcitriol is used in the synthesis of vitamin D3. | |||
T11646 | Impurity F of Calcipotriol | Others | |
Impurity F of Calcipotriol is a impurity of Calcipotriol. Calcipotriol (MC 903; Calcipotriene) is a ligand of VDR-like receptors. | |||
T11644 | Impurity C of Alfacalcidol | Others | |
Impurity of Alfacalcidol is an impurity of Alfacalcidol. Alfacalcidol is a non-selective VDR activator medication. | |||
T12123L | Cpd.5 of 1207358-59-5 | ||
Cpd.5 of 1207358-59-5 is a useful organic compound for research related to life sciences. The catalog number is T12123L and the CAS number is 1207365-47-6. | |||
T9559 | Cpd.7 of 1326852-06-5 | ||
Cpd.7 of 1326852-06-5 is a useful organic compound for research related to life sciences. The catalog number is T9559 and the CAS number is 2411843-75-7. | |||
TP2147 | LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) | Others | |
LSKL, Inhibitor of Thrombospondin (TSP-1) TFA, a latency-associated protein (LAP)-TGFβ derived tetrapeptide, is a competitive antagonist of TGF-β1. | |||
T11643 | Impurity B of Calcitriol | 1β,25-Dihydroxyvitamin-D3,1-Epicalcitriol | Others |
Impurity B of Calcitriol is an impurity of Calcitriol. Calcitriol is the hormonally active form of vitamin D, Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor (VDR). | |||
TP2291 | Signal transducer and activator of transcription 6 fragment | Others | |
The signal transducer and activator of transcription 6 fragments is a peptide with the sequence H2N-Ser-Tyr-Trp-Ser-Asp-Arg-Leu-Ile-Ile-OH, MW= 1152.3. | |||
T74446 | OF-02 | ||
OF-02, an alkenyl amino alcohol (AAA) ionizable lipid, demonstrates high potency for in vivo mRNA delivery. | |||
T30191 | Atecegatran | metabolite of AZD0837,atecegatran metoxil | |
Atecegatran is often used as an anticoagulant to treat cardiovascular disease. | |||
T83705 | BING TFA | Blocker of Inter-membrane Stress Responses of Gram-negative Bacteria | |
BING, a antimicrobial peptide discovered in Japanese medaka fish (O. laptipes), originates from vacuolar protein sorting-associated protein 13D-like (Vps13D). It exhibits efficacy against a range of Gram-negative and Gra... | |||
TQ0123 | MC 1046 | Impurity A of Calcipotriol | Others |
MC 1046 is an impurity of Calcipotriol. Calcipotriol is a ligand of VDR-like receptors. | |||
T11823 | LB-60-OF61 | NAMPT | |
LB-60-OF61 is a NAMPT inhibitor, a NAMPT inhibitor that displays antiproliferative activity against MYC oncogene-dependent cancer cell lines. | |||
TMIH-0155 | Prasugrel Metabolite Derivative-13C-d3 | Mixture of Diastereomers-13C-d3 | |
Prasugrel Metabolite Derivative-13C-d3 is the 13C and deuterated compound of Prasugrel Metabolite Derivative. | |||
T83733 | TIP39 (human, bovine) TFA | Tuberoinfundibular Peptide of 39 Residues | |
TIP39, a neuropeptide and an agonist for the parathyroid hormone receptor type 2 (PTH2R), effectively increases cAMP levels in COS-7 cells featuring recombinant PTH2R from humans or rats (EC50s = 0.5 and 0.8 nM, respecti... | |||
T34798 | Telapristone | metabolite of telapristone acetate (CDB-4124) | |
Telapristone, is the active metabolite of telapristone acetate (also known as CDB-4124). Telapristone is a selective progesterone receptor modulator (SPRM) being studied for the treatment of certain progesterone-sensitiv... | |||
T83763 | EPI-X4 TFA | Endogenous Peptide Inhibitor of CXCR4 | |
EPI-X4, an endogenous peptide fragment of human serum albumin (amino acids 408-423), serves as an antagonist to the chemokine (C-X-C motif) receptor 4 (CXCR4). It effectively prevents calcium mobilization and receptor in... | |||
T32981 | Lutenurine | Alkaloid complex of nuphar luteum,Liutenurin | |
Lutenurine is an alkaloid from yellow water lily; in treatment of skin and mucosal diseases. | |||
T14898 | CCG-63808 | GTPase | |
CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins. CCG-63808 dose-dependently inhibits the TR-FRET signal between RGS4-AF488 and Tb-Gαo with IC50 values of 1.9 μM. | |||
T20106 | C.I. 37558 | Naphtazol OP,NSC 50681,Azotol OF | |
C.I. 37558 is mainly used as an organic pigment intermediate. It can produce pigment red 170, pigment orange 22. | |||
T13457 | (Z)-9-Propenyladenine | (Z)-Mutagenic Impurity of Tenofovir Disoproxil | Others |
(Z)-9-Propenyladenine is a mutagenic impurity in tenofovir disoproxil fumarate. | |||
T14033 | 3BDO | Apoptosis , mTOR , Autophagy | |
3BDO is an activator of mTOR. It can also inhibit autophagy.. | |||
T26028 | RA VII | Methylether of TPC-A,RAVII,RA-VII | |
RA VII is used as an antitumor bicyclic hexapeptide of plant origin. | |||
T14897 | CCG-63802 | GTPase | |
CCG-63802 is a reversible inhibitor of the regulator of G-protein signaling (RGS) protein and has the greatest potency at RGS4. | |||
TMIH-0483 | Ractopamine-d6 (Mixture of Diastereomers) | ||
Ractopamine-d6 (Mixture of Diastereomers) is a deuterated compound of Ractopamine (Mixture of Diastereomers). | |||
T131583 | Thalibrunine and Isothalibrunine, mixture of | ||
Thalibrunine and Isothalibrunine, mixture of is a useful organic compound for research related to life sciences and the catalog number is T131583. | |||
T83775 | STING Agonist 12L | Stimulator of Interferon Genes Agonist 12L | |
STING agonist 12L is a stimulator of interferon genes (STING) agonist that exhibits binding affinity for both wild-type STING and its variants R232, AQ, and Q with half-maximal inhibitory concentrations (IC50s) of 1.15 µ... | |||
T83841 | STING Agonist D61 | D61,Stimulator of Interferon Genes Agonist D61 | |
STING agonist D61 is a compound that activates the stimulator of interferon genes (STING), leading to the induction of IFN3-inducible secreted alkaline phosphatase (SEAP) and IFN-β-inducible reporter genes in cellular as... | |||
T30321 | Bentazepam | Tiadipone,CI-718,Knoll brand of bentazepam,Thiadipone | |
Bentazepam is a thienodiazepine, which is a benzodiazepine analogue. It has anti-anxiety, anti-convulsion, sedative and skeletal muscle relaxation properties. | |||
T27210 | DRX-065 | DRX 065,DRX065,deuterated R-enantiomer of pioglitazone | |
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects,... | |||
TMIH-0484 | Ractopamine-d6 Hydrochloride (Mixture of Diastereomers) | ||
Ractopamine-d6 Hydrochloride (Mixture of Diastereomers) is a deuterated compound of Ractopamine Hydrochloride (Mixture of Diastereomers). | |||
T2358L | ENMD-2076 tartrate | ENMD-2076,L-(+) Tartrate salt of ENMD-981693,ENMD2076,ENMD 2076 | |
ENMD-2076 is an orally active kinase inhibitor. It also has antiangiogenic and antiproliferative mechanisms of action. | |||
TMIH-0315 | Lurasidone Inactive Metabolite 14283-d8 | 5α/6α-Hydroxy Lurasidone-d8 Hydrochloride (Mixture of Diastereomers) | |
Lurasidone Inactive Metabolite 14283-d8 is a deuterated compound of Lurasidone Inactive Metabolite 14283.Lurasidone Inactive Metabolite 14283 has a CAS number of 186204-31-9. | |||
T7693 | Thiorphan | Neprilysin | |
Thiorphan is an neprilysin inhibitor (NEP; IC50 : 0.007 μM). | |||
T12127 | 9-Propenyladenine | Mutagenic Impurity of Tenofovir Disoproxil,Tenofovir Impurity 2 | Others |
9-Propenyladenine is a mutagenic impurity in tenofovir disoproxil fumarate. | |||
TMIH-0316 | Lurasidone Inactive Metabolite 14326-d8 | 5β/6β-Hydroxy Lurasidone-d8 Hydrochloride (Mixture of Diastereomers) | |
Lurasidone Inactive Metabolite 14326-d8 is a deuterated compound of Lurasidone Inactive Metabolite 14326.Lurasidone Inactive Metabolite 14326 has a CAS number of 186204-33-1. | |||
T6045 | Torin 1 | DNA-PK , PI3K , mTOR , Autophagy | |
Torin 1 is an effective inhibitor of mTORC1/2 with (IC50: 2 nM/10 nM); has 1000-fold selectivity for mTOR than PI3K. | |||
T66282 | 5-Norbornene-2-methylamine (mixture of isomers) | ||
5-Norbornene-2-methylamine (mixture of isomers) is a useful organic compound for research related to life sciences. The catalog number is T66282 and the CAS number is 95-10-3. | |||
T64709 | LSKL, INhibitor of Thrombospondin (TSP-1) trifluoroacetate | ||
LSKL, INhibitor of Thrombospondin (TSP-1) trifluoroacetate is a useful organic compound for research related to life sciences and the catalog number is T64709. | |||
T64399 | Dihydroartemisinin (mixture of α and β isomers) | ||
Dihydroartemisinin (mixture of α and β isomers) is a useful organic compound for research related to life sciences. The catalog number is T64399 and the CAS number is 131175-87-6. | |||
T6030 | XL388 | P450 , PI3K , mTOR | |
XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases. | |||
T40351 | MHY-1685 | mTOR | |
MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy. |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T4786 | D-Ribose(mixture of isomers) | D-Ribose,D-(-)-Ribose | Others , Endogenous Metabolite |
D-Ribose(mixture of isomers) (D-(-)-Ribose), commonly referred to as simply ribose, is a five-carbon sugar found in all living cells. Ribose is not an essential nutrient because it can be synthesized by almost every tiss... | |||
T5680 | Aloin(mixture of A&B) | MMP , IL Receptor , Antibacterial , Antifungal | |
ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells. | |||
TN3604 | Carveol | (-)-Carveol, mixture of isomers | Endogenous Metabolite |
(-)-Carveol ((-)-Carveol, mixture of isomers), mixture of isomers is a monocyclic monoterpenic alcohol, present in essential oils of plant species such as Cymbopogon giganteus, Illicium pachyphyllum and in spices such as... | |||
T8028 | Farnesyl acetate | Farnesyl Acetate (mixture of isomers) | Others |
Farnesyl acetate (Farnesyl Acetate (mixture of isomers)) is a flavouring compound identified in foods such as blueberries. | |||
T2742 | Aloin | Barbaloin,Barbalin,Aloin-A,Aloin(mixture of A&B),Barbaloin-A | Tyrosinase |
Aloin (Aloin-A)(mixture of A&B), a natural anthracycline from Aloe vera, is a tyrosinase inhibitor. | |||
T25253 | Cinnamtannin B-1 | Cinnamtannin B1 (constituent of cinnamomum verum bark),LDN 0022358,LDN-0022358,LDN0022358 | Antioxidant , COX |
Cinnamtannin B-1 (LDN 0022358) is an A-type proanthocyanidin contained in several plant species such as Vaccinium vitis-idaea, Laurus nobilis L., Cinnamomum zeylanicum, and Lindera umbellata. It is a potent antioxidant a... | |||
T73954 | Leucinostatin (mixture of A&B) | ||
Leucinostatin, a mixture of components A and B, constitutes the primary elements of a unique nonapeptide complex synthesized by Paecilomyces lilacinus, functioning as antibiotics [1]. | |||
T2717 | Salidroside | Rhodioloside | Apoptosis , mTOR |
Salidroside (Rhodioloside) is a bioactive phenolic glycoside compound isolated from Rhodiola crenulata. It is a prolyl endopeptidase Inhibitor. | |||
TN1651 | Furanodiene | Apoptosis , PARP , Reactive Oxygen Species , Caspase , CDK , P-gp | |
Furanodiene has anti-inflammatory and antioxidant activities, it is active against gram-positive bacteria and Candida albicans. | |||
T8152 | 6-Demethoxytangeretin | MAPK , ALK | |
6-Demethoxytangeretin is a citrus flavonoid isolated from Citrus depressa. | |||
T2998 | Dihydromyricetin | Ampelopsin,Ampeloptin | Influenza Virus , GABA Receptor , DNA/RNA Synthesis , mTOR , Autophagy |
Dihydromyricetin (Ampelopsin) is a natural antioxidant flavonoid from Ampelopsis grossedentata. Dihydromyricetin is a potent inhibitor of dihydropyrimidinase with an IC50 of 48 μM. Dihydromyricetin can activate autophagy... | |||
T3S0012 | Coniferyl ferulate | P-gp , GST | |
Coniferyl ferulate is a strong inhibitor of glutathione S-transferase (GST) isolated from Radix Angelicae sinensis. It shows strong inhibition of human placental GST (IC50: 0.3 μM). It also reverses multidrug resistance ... | |||
T5S0506 | Rotundic acid | Rutundic acid | Apoptosis , Others , p38 MAPK , Akt , mTOR |
Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) c... | |||
T3O2749 | L-Leucine | (S)-Leucine,Leu | mTOR |
L-Leucine ((S)-Leucine) is one of nine essential amino acids in humans (provided by food), L-Leucine is important for protein synthesis and many metabolic functions. L-Leucine contributes to regulation of blood-sugar lev... | |||
T3895 | Polyphyllin I | Apoptosis , Akt , JNK , PDK , mTOR , Autophagy | |
Polyphyllin D induces apoptosis via the mitochondrial apoptotic pathway as evidenced by decreased Bcl-2 expression levels, disruption of MMP and increased Bax, cytochrome C, and cleaved-caspase-3 levels. Polyphyllin D ha... | |||
T2S0223 | Isosinensetin | 6-Demethoxynobiletin | Antioxidant , HIV Protease , Antibacterial , P-gp |
1. Isosinensetin (6-Demethoxynobiletin) shows antioxidant and HIV-1 protease inhibiting activities. | |||
TN4761 | Phellamurin | P-gp | |
Phellamurin inhibits intestinal P-glycoprotein in a dose-dependent manner, there is a serious interaction occurred between Phellamurin with cyclosporin, to ensure the efficacy of cyclosporin, we suggest that the coadmini... | |||
TN1305 | Ethoxysanguinarine | 6-Ethoxydihydrosanguinarine | Apoptosis , AChR |
Ethoxysanguinarine (6-Ethoxydihydrosanguinarine) shows human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity, with IC50 values of 0.83 +/- 0.04 microM and 4.20 +/-... | |||
T2230 | Paeoniflorin | Peoniflorin | HSP , COX |
Paeoniflorin (Peoniflorin) is a herbal constituent extracted from the root of Paeonia albiflora Pall. | |||
T3002 | Piperine | 1-Piperoylpiperidine,Bioperine | P450 , Endogenous Metabolite , P-gp , Autophagy |
Piperine (Bioperine) , a alkaloid, has been used in trials studying the treatment of multiple myeloma and deglutition disorders. | |||
TN1405 | Arnicolide D | Akt , Caspase , PI3K , STAT , mTOR | |
Arnicolide D is a sesquiterpene lactone. Arnicolide D isolates from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling path... | |||
T6354 | (+)-Usnic acid | D-Usnic Acid,(+)-Usniacin | Antiviral , Antibacterial , mTOR |
(+)-Usnic acid (D-Usnic Acid) is a naturally occurring dibenzofuran derivative found in several lichen species. | |||
TJS1159 | Chrysosplenetin | Chrysosptertin B | P450 , Ferroptosis , P-gp |
Chrysosplenetin is a metabolic inhibitor of artemisinin. | |||
T2S0271 | Voacamine | Voacanginine | Cannabinoid Receptor , P-gp |
Voacamine (Voacanginine) is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.Voacangini... | |||
T6S0033 | Crotonoside | Isoguanosine,2-HYDROXYADENOSINE | Others , FLT , HDAC |
1. Crotonoside (Isoguanosine) has much more active than adenosine in reducing the blood pressure in rabbits and cats, in decreasing the tone of isolated intestinal strips of the rabbit, guinea pig and hamster and in stim... | |||
T2S1200 | Sinapine | Antioxidant , P-gp , AChE | |
1. Sinapine, an alkaloid from seeds of the cruciferous species, can be used as an effective natural compound for chemo-resistance. 2. Sinapine has antioxidant and radio-protective activities. | |||
T2974 | Cyclovirobuxine D | CVB-D,Bebuxine,Cyclovirobuxin D | Apoptosis , Others , Akt , mTOR , Autophagy |
Cyclovirobuxine D (Bebuxine) is extracted from Buxus microphylla. | |||
T4034 | Solamargine | Solamargin,δ-Solanigrine | Apoptosis , p38 MAPK , P-gp , STAT |
Solamargine (δ-Solanigrine) is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cel... | |||
T5740 | 25(R,S)-Ruscogenin | (25RS)-Ruscogenin | Others , HIF |
25(R,S)-Ruscogenin is a natual product. | |||
T3392 | Sinapine thiocyanate | P-gp , AChE | |
Sinapine Thiocyanate, is a derivative of Sinapine (S486605), an alkaloidal amine found in black mustard seeds. It is the choline ester of Sinapic Acid (S486800). It is also a phenolic-chloine conjugates, acting as anti-o... | |||
T2P2806 | Hederacolchiside A1 | Raddeanoside R13 | Apoptosis , ERK , MEK , Akt , PI3K , Parasite , mTOR |
Hederacolchiside A1 (Raddeanoside R13) shows anti-leishmanial activity, it exhibits a strong antiproliferative activity on all stages of development of the parasite by altering membrane integrity and potential. Hederacol... | |||
T1537 | Rapamycin | Sirolimus,AY 22989,NSC-2260804 | Others , Endogenous Metabolite , Antibiotic , mTOR , Autophagy , Antifungal |
Rapamycin (AY 22989) is a natural product of macrolides, an mTOR inhibitor with specificity (HEK293 cells: IC50=0.1 nM). Rapamycin has immunosuppressive activity and induces autophagy. | |||
T2799 | (20S)-Protopanaxadiol | 20-Epiprotopanaxadiol,20(S)-APPD | Apoptosis , Reactive Oxygen Species , P-gp |
(20S)-Protopanaxadiol (20-Epiprotopanaxadiol) (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin. | |||
TN1525 | Convallatoxin | NF-κB , P-gp , PPAR | |
Convallatoxin is a natural product | |||
TN1757 | Hypophyllanthin | Potassium Channel , Calcium Channel , P-gp | |
Hypophyllanthin and phyllanthin have antitumour effects against Ehrlich Ascites Carcinoma in mice. | |||
TCS2336 | Evodine | P-gp | |
1. Evodine has antinociceptive activity. | |||
T2851 | Daphnetin | 7,8-Dihydroxycoumarin,Daphnetol | EGFR , PKA , PKC , Parasite , Autophagy |
Daphnetin (7,8-Dihydroxycoumarin), a natural coumarin derivative, is a protein kinase inhibitor with inhibitory for EGFR (IC50: 7.67 μM), PKA (IC50: 9.33 μM), and PKC (IC50: 25.01 μM), also exhibit anti-oxidant and anti-... | |||
T4085 | Paris saponin VII | Chonglou Saponin VII,Polyphyllin-VII,Dioscinin,Paris saponin-VII | Apoptosis , BCL , Others , PARP , p38 MAPK , Akt , Caspase , P-gp , Autophagy |
Paris saponin VII (Dioscini) shows inhibitory effects on cell proliferation. | |||
T6627 | Phosphoramidon Disodium | Phosphoramidon Disodium Salt | RAAS , Neprilysin , Others |
Phosphoramidon Disodium (Phosphoramidon Disodium Salt) Salt is a metalloendopeptidase inhibitor, widely used as a biochemical tool. | |||
TN3150 | 6,8-Diprenylnaringenin | Senegalensin,Lonchocarpol A | BCRP , ABC |
T7977 | Benzofuroxan | Others | |
Benzofuroxan is used as a starting material for the synthesis of other compounds, such as drugs and other chemicals; it is also used in the synthesis of polymers; it is also used in the synthesis of fluorescent dyes and ... | |||
T3417 | Amentoflavone | Didemethyl-ginkgetin,Amenthoflavone,3',8''-Biapigenin | Apoptosis , P450 , Phospholipase , Reactive Oxygen Species , Opioid Receptor , COX , Antibacterial , RSV , Antifungal |
Amentoflavone (3',8''-Biapigenin), as a potent inhibitor of CYP3A4 and CYP2C9, can interact with many other medications. CYP3A4 and CYP2C9 are proteins used for drug metabolism in the body. Amentoflavone also is an inhib... | |||
T1276 | Danofloxacin mesylate | CP 76136-27 | DNA/RNA Synthesis , Antibacterial , Antibiotic |
Danofloxacin mesylate (CP 76136-27) is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase. | |||
T24729 | Roseoflavin | Antibacterial | |
Roseoflavin, a chemical analog of FMN and riboflavin that has antimicrobial activity, can directly bind to FMN riboswitch aptamers and downregulate the expression of an FMN riboswitch-lacZ reporter gene in B. subtilis. | |||
T13516 | 5-Methyltetrahydrofolic acid | 5-Methyl THF | Endogenous Metabolite |
5-Methyltetrahydrofolic acid (5-Methyl THF) is a biologically active form of folic acid and a methylated derivate of tetrahydrofolate. It is the predominant natural dietary folate and the principal form of folate in plas... | |||
T5S0045 | Isofraxidin | 6,8-Dimethoxyumbelliferone,Phytodolor | MMP , ERK , p38 MAPK , TLR , COX |
1. Isofraxidin (Phytodolor) protects leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner. 2. Isofraxidin has a protective effect against LPS-induced ALI, and the prote... | |||
T2O2744 | Alpha-Naphthoflavone | 7,8-benzoflavone | Aromatase |
alpha-Naphthoflavone (7,8-benzoflavone), a synthetic flavonoid, is a potent inhibitor of aromatase with an I50 value of 0.5 μM. | |||
TN1520 | Isoforskolin | Coleonol B | IL Receptor , TNF |
Isoforskolin is derived from Coleus forskohlii and reduces the secretion of TNF-α, IL-1β, IL-6 and IL-8 in human mononuclear leukocytes. Isoforskolin can be used in studies about the treatment of Lyme arthritis. | |||
T3S1319 | (+)-Magnoflorine | Escholin,Magnoflorine,Thalictrin,Escholine | Others , Antifungal |
(+)-Magnoflorine (Thalictrin) has sedative and anxiolytic effects, probably mediated by Magnoflorine through a GABAergic mechanism of action. Magnoflorine and Sinomenine have protective effects, are mediated by some mech... | |||
TN1860 | Licoflavone B | ATPase , Anti-infection , Parasite | |
Licoflavone B has schistosomicidal activity, it showed high S. mansoni ATPase (IC50 of 23.78 μM) and ADPase (IC50 of 31.50 μM) inhibitory activities. | |||
------------------------ More ------------------------ |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-02811 | FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.5 kDa and the accession number is Q61559&P01887. | |||
TMPY-01991 | CD32A Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated | Cynomolgus | HEK293 Cells |
CD32A Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 22.9 kDa and the accession number is Q8SPW4. | |||
TMPY-05650 | FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated | Cynomolgus | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 45.3 kDa and the accession number is Q8SPV... | |||
TMPY-02829 | FCGRT & B2M Heterodimer Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 44 kDa and the accession number is P13599&P07151. | |||
TMPY-02830 | FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.5 kDa and the accession number is Q8SPV9&Q8SPW0. | |||
TMPY-02018 | CD16a Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
CD16a Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.7 kDa and the accession number is A0A8L2QKY4. | |||
TMPY-05538 | CD16a Protein, Cynomolgus, Recombinant (His), Biotinylated | Cynomolgus | HEK293 Cells |
CD16a Protein, Cynomolgus, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23.1 kDa and the accession number is Q8SPW2.1. | |||
TMPY-05539 | FCGRT & B2M Heterodimer Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.5 kDa and the accession number is P55899&P61769. | |||
TMPY-02082 | FCGRT & B2M Heterodimer Protein, Human, Recombinant (His) | Human | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.5 kDa and the accession number is P55899-1&P61769. | |||
TMPY-01990 | CD32B/Fcgr2b Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated | Cynomolgus | HEK293 Cells |
CD32B/Fcgr2b Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 23.5 kDa and the accession number is Q8SPW3. | |||
TMPY-00716 | CD89 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
CD89 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25 kDa and the accession number is P24071-1. | |||
TMPJ-00662 | RANKL/TNFSF11/CD254 Protein, Human, Recombinant (E. coli) | Human | E. coli |
CD254, also known as RANKL, TNFSF11, TRANCE, OPGL and ODF, is a type II membrane protein of the tumor necrosis factor (TNF) superfamily, and affects the immune system and control bone regeneration and remodeling. RANKL i... | |||
TMPY-06624 | STAT3 Protein, Human, Recombinant (His) | Human | E. coli |
STAT3 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 65.31 kDa and the accession number is P40763-1. | |||
TMPY-05084 | Fc epsilon RI Protein, Human, Recombinant | Human | HEK293 Cells |
Fc epsilon RI Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 21 kDa and the accession number is P12319. | |||
TMPY-03054 | Fc epsilon RI Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Fc epsilon RI Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.5 kDa and the accession number is P12319. | |||
TMPJ-00607 | RANKL/TNFSF11/CD254 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
RANKL/TNFSF11/CD254 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with N-6xHis tag. The predicted molecular weight is 30-35 KDa and the accession number is BAA97257.1. | |||
TMPY-02603 | STAT6 Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
Signal transducer and activator of transcription 6 (STAT6) is a transcription factor that is activated by interleukin-4 (IL-4)-induced tyrosine phosphorylation and mediates most of the IL-4-induced gene expression. STAT6... | |||
TMPY-02906 | CD16b Protein, Human, Recombinant (NA2,His) | Human | CHO Cells |
CD16b Protein, Human, Recombinant (NA2,His) is expressed in CHO mammalian cells with His tag. The predicted molecular weight is 22.2 kDa and the accession number is O75015.2. | |||
TMPY-01968 | CD32A Protein, Human, Recombinant (167 His, His) | Human | HEK293 Cells |
CD32A Protein, Human, Recombinant (167 His, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22 kDa and the accession number is P12318-1. | |||
TMPY-00701 | CD16b Protein, Human, Recombinant (NA2, His) | Human | HEK293 Cells |
CD16b Protein, Human, Recombinant (NA2, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.2 kDa and the accession number is O75015.2. | |||
TMPY-02442 | ELK1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells |
E twenty-six (ETS)-like transcription factor 1, also known as Elk1 or Member of ETS oncogene family (ELK1), is a member of the ETS oncogene superfamily which is characterized by a common protein domain that regulates DNA... | |||
TMPY-03241 | KIRREL3 Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
KIRREL3 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56.4 kDa and the accession number is Q09GS6. | |||
TMPY-02080 | CD32A Protein, Rhesus, Recombinant (His) | Rhesus | HEK293 Cells |
CD32A Protein, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.7 kDa and the accession number is H9BMP0. | |||
TMPJ-01206 | Sting Protein, Human, Recombinant (Sumo & His) | Human | E. coli |
Stimulator of Interferon Gene(Sting,TMEM173) belongs to the TMEM173 family. STING is 379 amino acids (aa) in length. It contains an N-terminal cytoplasmic region (aa 1-20), four transmembrane segments (aa 21-173), and a ... | |||
TMPY-05149 | FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His), Biotinylated | Cynomolgus | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.5 kDa and the accession number is Q8SPV9&Q8SPW0. | |||
TMPY-05148 | FCGRT & B2M Heterodimer Protein, Rat, Recombinant (His), Biotinylated | Rat | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Rat, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 44 kDa and the accession number is P13599&P07151. | |||
TMPY-02714 | PRC1 Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
PRC1 (protein regulator of cytokinesis 1) is a key regulator of cytokinesis that cross-links antiparrallel microtubules at an average distance of 35 nM. It is essential for controlling the spatiotemporal formation of the... | |||
TMPY-01975 | CD32A Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
CD32A Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.8 kDa and the accession number is Q8SPW4. | |||
TMPY-06706 | CD32A Protein, Rhesus, Recombinant (hFc) | Rhesus | HEK293 Cells |
CD32A Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 47.13 kDa and the accession number is NP_001244229.1. | |||
TMPY-05261 | CD32A Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
CD32A Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.2 kDa and the accession number is A0A8L2Q236. | |||
TMPY-06713 | CD32A Protein, Cynomolgus, Recombinant (hFc) | Cynomolgus | HEK293 Cells |
CD32A Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 48.04 kDa and the accession number is AAL92096.1. | |||
TMPY-05649 | FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His & Avi), Biotinylated | Mouse | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 46 kDa and the accession number is Q61559. | |||
TMPY-04020 | FCMR/FAIM3 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
FCMR/FAIM3 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 53 kDa and the accession number is O60667-1. | |||
TMPY-01964 | CD16a Protein, Human, Recombinant (F176V, His) | Human | HEK293 Cells |
The Fc receptor with low affinity for IgG (FCGR3, or CD16) is encoded by 2 nearly identical genes, FCGR3A and FCGR3B, resulting in tissue-specific expression of alternative membrane-anchored isoforms. FCGR3A, it is also ... | |||
TMPJ-00684 | SNCA Protein, Mouse, Recombinant (His) | Mouse | E. coli |
Alpha-synuclein (Snca) belongs to a family of proteins including a-, b-, and g-synucleins. Alpha-synuclein has been found to be implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson's ... | |||
TMPY-02071 | CD89 Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
CD89 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24.8 kDa and the accession number is NP_973721.1. | |||
TMPY-03457 | ERH Protein, Human, Recombinant (His) | Human | E. coli |
ERH(enhancer of rudimentary homolog) belongs to the E(R) family. It is expressed in all tissues examined. The monomeric structure of ERH comprises a single domain consisting of three α-helices and four β-strands, which... | |||
TMPY-00137 | CD32A Protein, Rat, Recombinant (hFc) | Rat | HEK293 Cells |
CD32A Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 47.5 kDa and the accession number is A0A8L2Q236. | |||
TMPY-06664 | CD32A Protein, Rhesus, Recombinant (His & Avi), Biotinylated | Rhesus | HEK293 Cells |
CD32A Protein, Rhesus, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 23.67 kDa and the accession number is NP_001244229.1. | |||
TMPH-01207 | DOCK8 Protein, Human, Recombinant (His) | Human | P. pastoris (Yeast) |
Guanine nucleotide exchange factor (GEF) which specifically activates small GTPase CDC42 by exchanging bound GDP for free GTP. During immune responses, required for interstitial dendritic cell (DC) migration by locally a... | |||
TMPY-05147 | FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His), Biotinylated | Mouse | HEK293 Cells |
FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 44.2 kDa and the accession number is Q61559&P01887. | |||
TMPY-00800 | CD32B/Fcgr2b Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
CD32B/Fcgr2b Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.7 kDa and the accession number is A0A0B4J1E6. | |||
TMPJ-00023 | SNCA Protein, Human, Recombinant (His) | Human | E. coli |
SNCA Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 18 KDa and the accession number is P37840. | |||
TMPY-02981 | ING5 Protein, Human, Recombinant (GST) | Human | E. coli |
ING5 belongs to the ING family. It contains 1 PHD-type zinc finger and is a component of the HBO1 complex. HBO1 complex has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is re... | |||
TMPJ-00850 | ST2/IL-1 RL1 Protein, Mouse, Recombinant (aa 27-337, His) | Mouse | HEK293 Cells |
ST2/IL-1 RL1 Protein, Mouse, Recombinant (aa 27-337, His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 55-70 KDa and the accession number is P14719-2. | |||
TMPY-04131 | KIRREL Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
KIRREL Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 78.8 kDa and the accession number is Q96J84-1. | |||
TMPH-02623 | DOCK8 Protein, Mouse, Recombinant (His) | Mouse | P. pastoris (Yeast) |
Guanine nucleotide exchange factor (GEF) which specifically activates small GTPase CDC42 by exchanging bound GDP for free GTP. During immune responses, required for interstitial dendritic cell (DC) migration by locally a... | |||
TMPJ-00683 | SNCA Protein, Mouse, Recombinant | Mouse | E. coli |
SNCA Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 17 KDa and the accession number is O55042. | |||
TMPY-01985 | CD32B/Fcgr2b Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
CD32B/Fcgr2b Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 24 kDa and the accession number is P31994-2. | |||
TMPY-03498 | ING4 Protein, Human, Recombinant (His) | Human | E. coli |
ING4 is similar to ING1, a tumor suppressor protein that can interact with TP53, inhibit cell growth, and induce apoptosis. ING4 contains a PHD-finger, which is a common motif in proteins involved in chromatin remodeling... | |||
------------------------ More ------------------------ |
カタログ番号 | 製品名 | ||
---|---|---|---|
L6900 | Rare Natural Product Library | 693 compounds | |
A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
L1000 | Approved Drug Library | 2808 compounds | |
A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L5610 | Golden Scaffold Library | 10000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source; | |||
L9410 | Covalent Inhibitor Library | 1920 compounds | |
A unique collection of 1920 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. | |||
L6010 | Natural Product Library | 3840 compounds | |
A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L1120 | AMPK-Targeted Compound Library | 80 compounds | |
80 well-chosen unique AMPK-targeted small molecules; | |||
L7820 | High Solubility Micro Fragment Library | 1081 compounds | |
The compound library of highly soluble micro-fragments consists of 1081 low-molecular-weight fragments. | |||
L4520 | Anti-Bacterial Compound Library | 904 compounds | |
A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L8600 | Ubiquitination Compound Library | 210 compounds | |
A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening; | |||
L4400 | Antibiotics Library | 692 compounds | |
A unique collection of 692 compounds with antibiotic activity for new antibacterial drug screening; | |||
L7110 | Anti-Hypertension Compound Library | 678 compounds | |
678 hypertension-related small molecules for high-throughput and high-content screening. | |||
L3900 | DNA Damage & Repair Compound Library | 910 compounds | |
A unique collection of 910 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9830 | Anti-Parkinson's Disease Compound Library | 857 compounds | |
A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
L7400 | Sodium Channel Blocker Library | 118 compounds | |
A unique collection of 118 sodium channel blockers and agonists for high throughput and high content screening; | |||
L4600 | Selected Plant-Sourced Compound Library | 3048 compounds | |
A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
L2910 | Antioxidant Compound Library | 1314 compounds | |
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ... | |||
L1900 | Anti-Diabetic Compound Library | 683 compounds | |
A unique collection of 683 diabetes related compounds; | |||
L6810 | Traditional Chinese Medicine Monomer Library | 2755 compounds | |
A unique collection of 2755 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism; | |||
L8000 | Stem Cell Differentiation Compound Library | 1197 compounds | |
A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
L9500 | Target-Focused Phenotypic Screening Library | 1796 compounds | |
A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | |||
L5400 | Anti-Cardiovascular Disease Compound Library | 1408 compounds | |
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L4900 | Cardiotoxicity Compound Library | 131 compounds | |
A unique collection of 131 cardiotoxicity inducing compounds for toxicological study; | |||
L2190 | Anti-Lung Cancer Compound Library | 1702 compounds | |
A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | |||
L8100 | Cell Cycle Compound Library | 677 compounds | |
A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1200 | Epigenetics Compound Library | 953 compounds | |
Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L9840 | Anti-Alzheimer's Disease Compound Library | 986 compounds | |
A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
L8500 | HIF-1 Signaling Pathway Compound Library | 1336 compounds | |
A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies; | |||
L5510 | Drug-induced Liver Injury (DILI) Compound Library | 1001 compounds | |
A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | |||
L6110 | Alkaloid Natural Product Library | 464 compounds | |
A unique collection of 464 natural alkaloids can be used for high throughput and high content screening; | |||
L1310 | Cytoskeletal Signaling Pathway Compound Library | 759 compounds | |
A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS; | |||
L3980 | DNA Damage and Repair Compound Library Plus | 667 compounds | |
Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
L3800 | NF-κB Signaling Compound Library | 729 compounds | |
A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
L6160 | RO5 Drug-like Natural Product Library | 2703 compounds | |
A unique collection of 2703 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
L6001 | Mini Fungal Metabolite Natural Product Screening Library | Inquiry | |
L2180 | Anti-Cancer Compound Library Plus | 1468 compounds | |
Well-chosen 1468 anti-tumor compounds with unique structures; | |||
L6030 | Natural Product Derivatives Library for CADD | 163000 compounds | |
Large quantity: contains 163,000 natural product derivatives and the number is continuously updating; | |||
L8400 | Hematonosis Compound Library | 514 compounds | |
A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
L2501 | Human Endogenous Metabolite Compound Library Plus | 1283 compounds | |
L5300 | Mitochondria-Targeted Compound Library | 812 compounds | |
A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
L7000 | Bioactive Lipid Compound Library | 385 compounds | |
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ... | |||
L5100 | Fluorochemical Library | 574 compounds | |
A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
L2520 | Glycometabolism Compound Library | 702 compounds | |
702 glycometabolism-related comounds, can be used for HTS and HCT; | |||
L6020 | Selectable Natural Product Library | 16627 compounds | |
A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species; | |||
L6210 | Tibetan medicine Compound Library | 747 compounds | |
A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
L7830 | High Solubility Pharmacophore Fragment Library | 985 compounds | |
High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
L2000 | Inhibitor Library | 8328 compounds | |
A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L6600 | Anti-Gastroenteritis Natural Product Library | 219 compounds | |
A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
L4100 | TGF-beta/Smad Compound Library | 184 compounds | |
A unique collection of 184 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
L6150 | Covalent Natural Product Library | 583 compounds | |
Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
L7700 | Neural Regeneration Compound Library | 524 compounds | |
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
L2510 | Lipid Metabolism Compound Library | 492 compounds | |
A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
L6120 | Flavonoid Natural Product Library | 514 compounds | |
A unique collection of 514 flavonoids can be used for high throughput and high content screening; | |||
L2610 | Neurotransmitter Receptor Compound Library | 1513 compounds | |
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | |||
L3700 | JAK-STAT Compound Library | 252 compounds | |
A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
L7200 | Calcium Channel Compound Library | 140 compounds | |
A unique collection of 140 calcium channel blockers and agonists for high throughput and high content screening; | |||
L4010 | Bioactive Compounds Library Max | 22555 compounds | |
A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
L6140 | Saccharide and Glycoside Natural Product Library | 595 compounds | |
A unique collection of 595 saccharides and glycosides compounds can be used for HTS and HCS; | |||
L9300 | Macrocyclic Compound Library | 210 compounds | |
210 macrocyclic compounds of known activity for high-throughput, high-content screening; | |||
L4500 | Anti-Fungal Compound Library | 252 compounds | |
A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
L9210 | Pediatric Drug Library | 972 compounds | |
A unique collection of 972 pediatric drugs for high-throughput screening and high-content screening. | |||
L8800 | Drug-Fragment Library | 1119 compounds | |
1119 drug fragments,a must-have tool for FBDD; | |||
L8200 | Anti-Aging Compound Library | 3279 compounds | |
A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6230 | Miao medicine Compound Library | 534 compounds | |
A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening. | |||
L2170 | Immuno-Oncology Compound Library | 449 compounds | |
A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L1300 | PI3K-AKT-mTOR Compound Library | 420 compounds | |
A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
LF1000 | Pre-plated Diversity Sets | 50000 compounds | |
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap. | |||
L2192 | Anti-Pancreatic Cancer Compound Library | 2238 compounds | |
A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS; | |||
L7300 | Potassium Channel Blocker Library | 152 compounds | |
A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening; | |||
L9400 | PPI Inhibitor Library | 485 compounds | |
A unique collection of 485 PPI-related compounds for drug screening; | |||
L1510 | Nuclear Receptor Compound Library | 531 compounds | |
A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
L2550 | Glutamine Metabolism Compound Library | 565 compounds | |
A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ... | |||
L8700 | Ferroptosis Compound Library | 779 compounds | |
A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; | |||
L1500 | GPCR Compound Library | 1940 compounds | |
A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
L1580 | GPCR Compound Library Plus | 338 compounds | |
Well-chosen 338 GPCR targeting compounds with unique structures; | |||
L3200 | Autophagy Compound Library | 1248 compounds | |
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L2200 | Tyrosine Kinase Inhibitor Library | 1016 compounds | |
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
L3500 | Histone Modification Compound Library | 469 compounds | |
A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9610 | Cyclic Peptide Library | 55 compounds | |
55 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
L2700 | Adrenergic Receptor-Targeted Compound Library | 193 compounds | |
A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
L7100 | Anti-Obesity Compound Library | 2247 compounds | |
A unique collection of 2247 anti-obesity compounds for high throughput and high content screening; | |||
L6000 | Natural Product Library for HTS | 4533 compounds | |
A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can... | |||
L2620 | Anti-Neurodegenerative Disease Compound Library | 2154 compounds | |
A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS; | |||
L6710 | Anti-Inflammatory Traditional Chinese Medicine Compound Library | 1246 compounds | |
A collection of 1246 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study; | |||
L3300 | Histamine & Melatonin Receptor-Targeted Compound Library | 153 compounds | |
A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L9000 | Apoptosis Compound Library | 1760 compounds | |
A unique collection of 1760 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
L9230 | ReFRAME Related Library | 3210 compounds | |
A unique collection of 3210 compounds for high-throughput screening and high-content screening, | |||
L4300 | Wnt/Hedgehog/Notch Compound Library | 237 compounds | |
A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
L2130 | Anti-Cancer Metabolism Compound Library | 1268 compounds | |
A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
L2191 | Anti-Breast Cancer Compound Library | 1939 compounds | |
A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | |||
L9860 | Antidepressant Compound Library | 1163 compounds | |
1163 compounds associated with depression that can be used for high-throughput and high-content screening | |||
L9600 | Peptide Compound Library | 791 compounds | |
791 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
L8110 | Reprogramming Compound Library | 1813 compounds | |
A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L6130 | Terpene Natural Product Library | 622 compounds | |
A unique collection of 622 natural terpenes and terpenoids can be used for high throughput and high content screening; | |||
L5200 | Anti-Metabolism Disease Compound Library | 1544 compounds | |
A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L3410 | Preclinical Compound Library | 701 compounds | |
A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6800 | Chinese Pharmacopoeia Natural Product Library | 2051 compounds | |
A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
L5800 | Drug Metabolite/Impurity Library | 197 compounds | |
A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
L2570 | Human Metabolite Library | 4454 compounds | |
A unique collection of 4454 human metabolites for high-throughput, high-content screening. | |||
L9100 | Phosphatase Inhibitor Library | 79 compounds | |
A collection of 79 phosphatase inhibitors with known activity; | |||
L7810 | High Solubility Polyfunctional Group Fragment Library | 1159 compounds | |
Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules. | |||
L6300 | Food as Medicine Compound Library | 1290 compounds | |
A unique collection of 1290 compounds from food as medicine for high throughput and high content screening; | |||
L2100 | Anti-Cancer Compound Library | 7234 compounds | |
A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L4800 | Angiogenesis related Compound Library | 1353 compounds | |
A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
L5700 | Featured Fragment Library | 246 compounds | |
A unique collection of 246 fragment-like small molecules for FBDD; | |||
L6400 | Marine Natural Product Library | 144 compounds | |
A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L1380 | Transcription Factor-Targeted Compound Library | 695 compounds | |
Well-chosen 695 compounds with unique structures targeting transcription factor; | |||
L1100 | Protease Inhibitor Library | 343 compounds | |
A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
L2600 | Neuronal Signaling Compound Library | 2540 compounds | |
A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L3100 | Hematopoietic Toxicity Compound Library | 101 compounds | |
A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
L6720 | Anti-COVID-19 Traditional Chinese Medicine Compound Library | 1147 compounds | |
A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; | |||
L9420 | Exosome Compound Library | 76 compounds | |
76 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
L1110 | Microtubule-Targeted Compound Library | 142 compounds | |
A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS; | |||
L3510 | Methylation Compound Library | 128 compounds | |
128 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
L1610 | FDA-Approved Kinase Inhibitor Library | 263 compounds | |
A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening. | |||
L7850 | High Solubility 3D Diversity Fragment Library | 1079 compounds | |
The library of highly soluble 3D structural diversity fragments contains 1079 compounds. | |||
L2800 | Serotonin Receptor-Targeted Compound Library | 268 compounds | |
A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
L2400 | Endocrinology-Hormone Compound Library | 784 compounds | |
A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L1400 | MAPK Inhibitor Library | 365 compounds | |
A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases; | |||
L6820 | Tobacco Monomer Library | 747 compounds | |
L8710 | Cuproptosis Compound Library | 400 compounds | |
TargetMol’s Cuproptosis Compound Library is a collection of 400 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
L5900 | CNS-Penetrant Compound Library | 509 compounds | |
A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1710 | Anti-COVID-19 Compound Library | 1133 compounds | |
A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | |||
DO2200 | Covalent inhibitors Library | 12000 compounds | |
L2151 | Chemotherapy Drug Library | 48 compounds | |
48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
L2196 | Anti-Ovarian Cancer Compound Library | 1867 compounds | |
L2300 | Ion Channel Inhibitor Library | 931 compounds | |
A unique collection of 931 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | |||
L2560 | Metabolism Compound Library | 2320 compounds | |
L9411 | Cysteine Covalent Library | 70 compounds | |
The cysteine covalent library contains 70 compounds. | |||
L2630 | Neuronal Differentiation Compound Library | 672 compounds | |
L7500 | Coagulation and Anticoagulation Compound Library | 144 compounds | |
A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6500 | Microbial Natural Product Library | 550 compounds | |
A unique collection of 550 microbial natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L6740 | Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library | 382 compounds | |
A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
L9900 | Inactive Ingredient Library | 182 compounds | |
L6730 | Anti-virus Traditional Chinese Medicine Monomer Library | 268 compounds | |
A collection of 268 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. | |||
L4510 | Anti-Parasitic Compound Library | 419 compounds | |
419 well-chosen unique anti-parasitic small molecules; | |||
L7900 | Osteogenesis Compound Library | 317 compounds | |
A unique collection of 317 osteogenesis related compounds for high throughput and high content screening; | |||
L6700 | Anti-Tumor Natural Product Library | 1772 compounds | |
A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L1720 | Nucleotide Compound Library | 334 compounds | |
A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
L6610 | Anti-infective Natural Product Library | 1060 compounds | |
A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L1700 | Anti-Viral Compound Library | 1040 compounds | |
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
L8300 | Chromatin Modification Compound Library | 250 compounds | |
A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
L4150 | Featured Novel Bioactive Compound Library | 989 compounds | |
It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis... | |||
L4000 | Bioactive Compound Library | 14439 compounds | |
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification; | |||
L2540 | Gut Microbial Metabolite Library | 614 compounds | |
A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS; | |||
L9850 | Orally Active Compound Library | 2427 compounds | |
A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening. | |||
L4660 | Anti-Nervous System Disease Library | 1246 compounds | |
Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
L4700 | Immunology/Inflammation Compound Library | 4720 compounds | |
A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
L2194 | Anti-Colorectal Cancer Compound Library | 1545 compounds | |
1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L1800 | Anti-Infection Compound Library | 2938 compounds | |
A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
L3400 | Clinical Compound Library | 3404 compounds | |
A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
L2521 | Glycolysis Compound Library | 555 compounds | |
555 glycolysis-related active compounds for high-throughput and high-content screening. | |||
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3158 compounds | |
3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2010 | Highly Selective Inhibitor Library | 575 compounds | |
L2160 | Anti-Cancer Active Compound Library | 3188 compounds | |
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L2150 | Anti-Cancer Drug Library | 3080 compounds | |
A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1600 | Kinase Inhibitor Library | 2720 compounds | |
A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
L2900 | Oxidation-Reduction Compound Library | 1264 compounds | |
1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
L2140 | Cancer Cell Differentiation Compound Library | 406 compounds | |
A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
L2500 | Human Endogenous Metabolite Library | 499 compounds | |
A collection of 499 selected human endogenous metabolites for high throughput and high content screening. | |||
L2120 | Anti-Cancer Clinical Compound Library | 2545 compounds | |
A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6620 | Antiparasitic Natural Product Library | 253 compounds | |
A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 compounds | |
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
L9001 | Food Additive Library | 425 compounds | |
L7870 | Carboxylic Acid Fragment Library With Solubility | 1806 compounds | |
L8720 | Pyroptosis Compound Library | 1066 compounds | |
1066 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
L2110 | Anti-Cancer Approved Drug Library | 1779 compounds | |
A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L6750 | PBCRBS Traditional Chinese Medicine Compound Library | 580 compounds | |
A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis. | |||
L6220 | Traditional Mongolian Medicine Compound Library | 950 compounds | |
A collection of 950 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
L9820 | Beta-Lactam Compound Library | 97 compounds | |
A unique collection of 97 beta-lactam compounds, can be used in HTS and HCS; | |||
L6200 | The Yao nationality medicine Library | 221 compounds | |
A collection of 221 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
L7600 | Chemokine Inhibitor Library | 59 compounds | |
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
L9810 | Anti-Fibrosis Compound Library | 1180 compounds | |
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
L5600 | Mini Scaffold Library | 5000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds; | |||
L4200 | FDA-Approved Drug Library | 1729 compounds | |
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L3600 | Cytokine Inhibitor Library | 604 compounds | |
A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
NY1000 | Natural Product Derivatives Library | 4000 compounds | |
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
L2193 | Anti-Liver Cancer Compound Library | 1787 compounds | |
1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | |||
L9200 | Drug Repurposing Compound Library | 4630 compounds | |
A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
DF4600 | Drug-like natural compound library | 522 compounds | |
L7800 | High Solubility Fragment Library | 2728 compounds | |
Structurally diverse, medicinally active, and unique chemistry (strong IP potential); | |||
L7840 | High Solubility FragLite Fragment Library | 796 compounds | |
The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
L5500 | Toxic Compound Library | 262 compounds | |
A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
L2530 | Mouse Metabolite Compound Library | 218 compounds | |
A unique collection of 218 mouse metabolites, which can be used for HTS and HCS; | |||
L6100 | Polyphenolic Natural Product Library | 635 compounds | |
A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9700 | Endoplasmic Reticulum Stress Compound Library | 193 compounds | |
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
L2195 | Anti-Prostate Cancer Compound Library | 2070 compounds | |
2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
L4020 | NO PAINS Compound Library | 9384 compounds | |
DO1200 | SmartTM Library | 53200 compounds | |
L2152 | Targeted Therapy Drug Library | 119 compounds | |
119 tumor-targeted drugs that can be used for high-throughput and high-content screening. |